Nephrogenic fibrosing dermopathy: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
{{Nephrogenic fibrosing dermopathy}} | {{Nephrogenic fibrosing dermopathy}} | ||
{{CMG}}'''Assistant Editor-in-Chief:''' [[Brian Blank]] | {{CMG}}''' Assistant Editor-in-Chief:''' [[Brian Blank]] | ||
{{SK}} nephrogenic systemic fibrosis | {{SK}} nephrogenic systemic fibrosis | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy overview|Overview]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy historical perspective|Historical Perspective]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy classification scheme|Classification]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy causes|Causes]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy differential diagnosis|Differentiating Nephrogenic fibrosing dermopathy from other Diseases]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy risk factors|Risk Factors]]== | ||
==[[ | ==[[Nephrogenic fibrosing dermopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[Nephrogenic fibrosing dermopathy history and symptoms|History and Symptoms ]] | [[ Nephrogenic fibrosing dermopathy physical examination|Physical Examination]] | [[Nephrogenic fibrosing dermopathy laboratory findings|Laboratory Findings]] | [[Nephrogenic fibrosing dermopathy x ray|X-Ray]] | [[Nephrogenic fibrosing dermopathy CT|CT]] | [[Nephrogenic fibrosing dermopathy MRI|MRI]] | [[Nephrogenic fibrosing dermopathy ultrasound|Ultrasound]] | [[Nephrogenic fibrosing dermopathy other imaging findings|Other Imaging Findings]] | [[Nephrogenic fibrosing dermopathy other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[Nephrogenic fibrosing dermopathy medical therapy|Medical Therapy]] | [[Nephrogenic fibrosing dermopathy surgery |Surgery]] | [[Nephrogenic fibrosing dermopathy secondary prevention|Secondary Prevention]] | [[Nephrogenic fibrosing dermopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nephrogenic fibrosing dermopathy future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[ | [[Nephrogenic fibrosing dermopathy case study one|Case #1]] | ||
==Source== | ==Source== |
Latest revision as of 15:18, 28 September 2012
Nephrogenic fibrosing dermopathy Microchapters |
Differentiating Nephrogenic fibrosing dermopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nephrogenic fibrosing dermopathy On the Web |
American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy |
Directions to Hospitals Treating Nephrogenic fibrosing dermopathy |
Risk calculators and risk factors for Nephrogenic fibrosing dermopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editor-in-Chief: Brian Blank
Synonyms and keywords: nephrogenic systemic fibrosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nephrogenic fibrosing dermopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X-Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Source